Infant Bacterial Therapeutics AB (publ) (IBT-B) — Working Capital to Net Assets Ratio
Infant Bacterial Therapeutics AB (publ) (IBT-B) has a Working Capital to Net Assets ratio of 93.3% as of September 2025. Working capital of Skr116.02 Million (current assets of Skr169.88 Million minus current liabilities of Skr53.87 Million) is measured against net assets of Skr124.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See IBT-B net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Infant Bacterial Therapeutics AB (publ) Working Capital to Net Assets (2013–2024)
This chart shows how Infant Bacterial Therapeutics AB (publ)'s Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 93.3%, reflecting working capital of Skr116.02 Million against net assets of Skr124.36 Million SEK. Check tangible equity quality of Infant Bacterial Therapeutics AB (publ) to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Infant Bacterial Therapeutics AB (publ) (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Infant Bacterial Therapeutics AB (publ) from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Infant Bacterial Therapeutics AB (publ) (IBT-B) market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 94.7% | Skr161.31 Million | Skr170.26 Million | Skr230.61 Million | Skr69.30 Million | ▼ -2.1 pp |
| 2023 | 96.8% | Skr295.38 Million | Skr305.15 Million | Skr341.56 Million | Skr46.18 Million | ▼ 0.0 pp |
| 2022 | 96.8% | Skr321.12 Million | Skr331.71 Million | Skr339.03 Million | Skr17.91 Million | ▼ -0.3 pp |
| 2021 | 97.1% | Skr383.87 Million | Skr395.25 Million | Skr397.09 Million | Skr13.22 Million | ▼ -0.1 pp |
| 2020 | 97.2% | Skr427.95 Million | Skr440.15 Million | Skr438.12 Million | Skr10.16 Million | ▼ -0.2 pp |
| 2019 | 97.4% | Skr497.38 Million | Skr510.40 Million | Skr505.26 Million | Skr7.88 Million | ▼ -0.1 pp |
| 2018 | 97.5% | Skr542.88 Million | Skr556.72 Million | Skr549.54 Million | Skr6.65 Million | ▲ +6.2 pp |
| 2017 | 91.3% | Skr153.72 Million | Skr168.37 Million | Skr160.38 Million | Skr6.65 Million | ▲ +5.9 pp |
| 2016 | 85.4% | Skr89.81 Million | Skr105.23 Million | Skr94.69 Million | Skr4.88 Million | ▲ +7.0 pp |
| 2015 | 78.3% | Skr58.58 Million | Skr74.81 Million | Skr66.32 Million | Skr7.73 Million | ▲ +33.4 pp |
| 2014 | 44.9% | Skr4.96 Million | Skr11.03 Million | Skr8.46 Million | Skr3.51 Million | ▼ -55.1 pp |
| 2013 | 100.0% | Skr1.05 Million | Skr1.05 Million | Skr1.29 Million | Skr240.70K | — |